Willingmed Secures Series B Funding to Advance Clinical Infection Diagnostics
Willingmed, a Beijing-based company specializing in molecular biology for clinical infection precision diagnosis, has reportedly...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity